NEVVI Medicare utilization intelligence

← back

ROSEN, ROBERTD.O. NPI 1275512840 Clinician

Dermatology · TOMS RIVER, NJ

Specialty Dermatology — from billed Medicare claims
Trained NEW YORK COLLEGE OF OSTEO MEDICINE OF NEW YORK INSTITUTE OF TECHNOLOGY — medical school, self-reported to CMS
In practice about 40 years since medical school (class of 1986, self-reported to CMS)
Location TOMS RIVER, NJ · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 43 codes billed · 5,547 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20262026
SCHWEIGER DERMATOLOGY PC
2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-10

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
17000 Destruction of precancer skin growth, 1 growth
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
11104 Punch biopsy, first skin growth
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
99202 New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
17110 Destruction of skin growth, 1-14 growths
11102 Biopsy of related skin growth, first growth
17311 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
17312 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks
11105 Punch biopsy, each additional skin growth
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
12032 Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm
11900 Injection into skin growth, 1-7 growths
11103 Biopsy of related skin growth, each additional growth
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm
12052 Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
10060 Simple or single drainage of skin abscess
11602 Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm
J9190 Injection, fluorouracil, 500 mg
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
11603 Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm
17313 Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks
69100 Biopsy of ear
12051 Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less
Q0112 All potassium hydroxide (koh) preparations
96405 Administration of chemotherapy into growth, 1-7
14060 Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less
96372 Injection of drug or substance under skin or into muscle
11642 Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
17260 Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less
17271 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm
17280 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
13132 Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm
13121 Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm
17272 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
17281 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
17314 Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.